<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Public Health</journal-id>
<journal-title>Frontiers in Public Health</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Public Health</abbrev-journal-title>
<issn pub-type="epub">2296-2565</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fpubh.2025.1529687</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Public Health</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>A mixed-method study to inform the design of a video observed therapy app to monitor individuals with TB in the Dominican Republic</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Canario-Guzm&#x00E1;n</surname> <given-names>Julio Arturo</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2826746/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Elias-Melgen</surname> <given-names>Ricardo</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Mendoza</surname> <given-names>Eddys Rafael</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref rid="fn00001" ref-type="author-notes"><sup>&#x2020;</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Arias</surname> <given-names>Luis Felipe</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref rid="fn00001" ref-type="author-notes"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2966321/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Espinal</surname> <given-names>Roberto</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>B&#x00E1;ez</surname> <given-names>Jeannette</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Iribarren</surname> <given-names>Sarah</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Centro Nacional de Investigaciones en Salud Materno Infantil Dr. Hugo Mendoza (CENISMI)</institution>, <addr-line>Santo Domingo</addr-line>, <country>Dominican Republic</country></aff>
<aff id="aff2"><sup>2</sup><institution>University of Washington</institution>, <addr-line>Seattle, WA</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0001">
<p>Edited by: Josef Yayan, University of Witten/Herdecke, Germany</p>
</fn>
<fn fn-type="edited-by" id="fn0002">
<p>Reviewed by: Richard S. Garfein, University of California, San Diego, United States</p>
<p>Neti Juniarti, Padjadjaran University, Indonesia</p>
</fn>
<corresp id="c001">&#x002A;Correspondence: Julio Arturo Canario-Guzm&#x00E1;n, <email>jcanario@etikos.org</email></corresp>
<fn id="fn00001" fn-type="present-address"><p><sup>&#x2020;</sup>PRESENT ADDRESS: Eddys Rafael Mendoza and Luis Felipe Arias, Fundaci&#x00F3;n Etikos, Inc., Calle Enrique Henriquez, Gazcue, Distrito Nacional, Dominican Republic</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>06</day>
<month>06</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>13</volume>
<elocation-id>1529687</elocation-id>
<history>
<date date-type="received">
<day>21</day>
<month>11</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>04</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2025 Canario-Guzm&#x00E1;n, Elias-Melgen, Mendoza, Arias, Espinal, B&#x00E1;ez and Iribarren.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Canario-Guzm&#x00E1;n, Elias-Melgen, Mendoza, Arias, Espinal, B&#x00E1;ez and Iribarren</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract xml:lang="es">
<sec id="sec1">
<title>Introduction</title>
<p>Video Observed-Therapy, a digital adherence technologies (DAT), could improve patients&#x2019; adherence to tuberculosis (TB) treatment. However, countries with high TB burden countries, such as the Dominican Republic, struggle to adopt DAT as a control and prevention tool to improve clinical outcomes. Objectives: To describe patients&#x2019; knowledge, attitudes and behaviors towards digital technologies for TB control and prevention in the Dominican Republic.</p>
</sec>
<sec id="sec2">
<title>Methods</title>
<p>A mixed-method study was implemented by organizing two Focus Group Discussions (FGDs) and a survey with 137 TB patients. Qualitative data were coded using the Integrated Behavior Model (IBM) and descriptive statistics were used to analyze knowledge, attitudes, practices, and preferences. Data integration was achieved by comparing convergent and divergent results.</p>
</sec>
<sec id="sec3">
<title>Results</title>
<p>Participants expressed a positive attitude towards using DAT to facilitate communication with health personnel to support treatment adherence. Participants noted the benefit of having an application that facilitates this process while safeguarding data privacy.</p>
</sec>
<sec id="sec4">
<title>Conclusion</title>
<p>This study demonstrates positive attitudes among individuals with TB toward adopting digital tools in their follow-up. Current practices suggest that intent to use DAT is prevalent, emphasizing the need to fully transition from intention to adoption of DAT to improve TB treatment outcomes.</p>
</sec>
</abstract>
<kwd-group>
<kwd>video observed therapy</kwd>
<kwd>digital adherence technologies</kwd>
<kwd>Tuberculosis</kwd>
<kwd>patient monitoring</kwd>
<kwd>Dominican Republic</kwd>
</kwd-group>
<contract-num rid="cn1">2018-2019-3A7-214</contract-num>
<contract-sponsor id="cn1">Ministry of Higher Education and Technology FONDOCyT</contract-sponsor>
<counts>
<fig-count count="0"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="43"/>
<page-count count="9"/>
<word-count count="6926"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Public Health Education and Promotion</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec5">
<label>1</label>
<title>Introduction</title>
<p>The World Health Organization (WHO) and global partners recognize the critical role of digital health in advancing the global response to tuberculosis (TB) and have designed a comprehensive digital health agenda (<xref ref-type="bibr" rid="ref1 ref2 ref3 ref4">1&#x2013;4</xref>). Despite these efforts, the adoption and integration of digital adherence technologies (DAT) in the health sector, particularly in low- and middle-income countries remains challenging (<xref ref-type="bibr" rid="ref5">5</xref>). The Dominican Republic (DR), with a high TB incidence rate, reported approximately 45 [33&#x2013;57] new TB cases per 100,000 inhabitants in 2021 (<xref ref-type="bibr" rid="ref6">6</xref>).</p>
<p>To reduce the burden of TB in the DR, the National TB Program (NTBP) of the Ministry of Public Health (MoPH) implements the Directly Observed Treatment Short-Course (DOTS) strategy. However, in 2020, 16% of the TB patients who started DOTS did not complete their treatment (<xref ref-type="bibr" rid="ref7">7</xref>). Several factors contribute to incomplete treatment including difficult access to healthcare, patient knowledge, poverty, drug use, comorbid illnesses, treatment-related adverse events, poor patient-provider communication, and self-treatment (<xref ref-type="bibr" rid="ref8 ref9 ref10">8&#x2013;10</xref>).</p>
<p>To achieve WHO target of 90% treatment success rate (<xref ref-type="bibr" rid="ref11">11</xref>), various initiatives have been made. These efforts include shortening treatment duration (<xref ref-type="bibr" rid="ref12">12</xref>), improving medication adherence, integrating digital technologies and health behavior models to increase effectiveness in changing behavior and improving medication. Digital technologies (short message services -SMSs- via mobile phones) and, more specifically, digital adherence technologies (DATs) tools designed to support individuals with TB with taking their medication (medication sleeves; smart pill boxes; video-observed treatment) (<xref ref-type="bibr" rid="ref13 ref14 ref15">13&#x2013;15</xref>).</p>
<p>From the available alternatives to increase treatment adherence, we proposed the use of Video Observed Therapy (VOT). In the Dominican Republic, the use of messaging and video application is widespread and widely accepted. Also, VOT could address barriers with DOTS, such as travel time and related costs (<xref ref-type="bibr" rid="ref16 ref17 ref18 ref19 ref20 ref21">16&#x2013;21</xref>). TB is considered a disease of the poverty, so patients can benefit from reducing the number of visits to the clinic. VOT as intervention has evidence of improvement medication adherence (<xref ref-type="bibr" rid="ref22">22</xref>).</p>
<p>At the inception of this study in 2018, VOT had not been implemented in the DR. The onset of the COVID-19 pandemic disrupted TB control efforts but accelerated global adoption of digital tools in TB programs (<xref ref-type="bibr" rid="ref5">5</xref>, <xref ref-type="bibr" rid="ref23">23</xref>). In response, the DR developed a new protocol to facilitate the use of DAT for remote TB patient follow-up. Extending drug supply periods and implementing remote monitoring and support proactively can mitigate the risk of patient loss to follow-up (<xref ref-type="bibr" rid="ref24 ref25 ref26 ref27">24&#x2013;27</xref>). The overall objective of this study was to explore and describe TB patient attitudes and behavior towards digital technologies for TB control and prevention.</p>
</sec>
<sec sec-type="methods" id="sec6">
<label>2</label>
<title>Methods</title>
<sec id="sec7">
<label>2.1</label>
<title>Study design</title>
<p>A convergent mixed-method design was used to pursue the aim of this study. Qualitative and quantitative components were combined to explore and describe TB patients&#x2019; attitudes and behavior, regarding using digital technologies in their TB care and management. Focus group discussions (FGDs) were held with nine individuals with TB, and 137 were surveyed between September and January 2021 in Santo Domingo, Dominican Republic. Ethical approval was obtained from the Research Ethics Committee at the Centro Nacional de Investigaciones en Salud Materno Infantil Dr. Hugo Mendoza (CENISMI) (#31082020). Written informed consent was obtained from all study participants. Confidentiality and data protection measures were undertaken by using encrypted laptops and files with restricted access to the study team and PI.</p>
</sec>
<sec id="sec8">
<label>2.2</label>
<title>Qualitative component: participant focus group discussions</title>
<p>A FGD guide with open-ended questions was developed based on the Integrated Behavioral Model (IBM) (<xref ref-type="bibr" rid="ref28">28</xref>) constructs, which combines constructs from the Theory of Reasoned Action (<xref ref-type="bibr" rid="ref29">29</xref>) and Planned Behavior (<xref ref-type="bibr" rid="ref30">30</xref>). Questions include, for example, have you ever used a telephone or a computer with the Internet to search for health information or monitor your health status? What do you like/dislike about the idea of reviewing a video recording of the patient taking medication at home and sending it to the doctor? We aimed to explore participants&#x2019; knowledge, attitudes, practices, and preferences for using digital technologies during their treatment. The questionnaire was discussed between the research team, and comments on content validation and language and cultural appropriateness of the questions. The questionnaire passed by different rounds of revision until a final version was agreed upon by the researchers. The questionnaire is in the Annex section.</p>
<p>The FGDs were conducted in TB Units in two health centers in the province of Santo Domingo (Boca Chica and Villa Mella). Inclusion criteria were being bacteriologically confirmed with TB, 18&#x202F;years of age and older, who had initiated or recently completed treatment (within the last 3&#x202F;months). Convenience sampling was used. Healthcare workers from the TB units recruited participants consecutively in person as they came in for follow-up appointments. If interested in participating, they were connected with a research team member who facilitated the informed consent process and scheduling the FGDs. Each FGDs session lasted approximately 1&#x202F;h and was audio-recorded.</p>
</sec>
<sec id="sec9">
<label>2.3</label>
<title>Quantitative component: survey</title>
<p>For the quantitative component, identical inclusion/exclusion criteria were applied. Participants were recruited from eight TB units across the province of Santo Domingo and the National District with the highest cases of TB in the country. Health care workers at TB units recruited participants. The survey was administered in person. The survey consisted of 58 questions in 6 sections: (a) sociodemographic, clinical, and adherence characteristics, (b) knowledge, (c) attitude, (d) practices, (e) access to health care, and (f) economic consequences. The questionnaire included questions on preferences for TB digital treatment monitoring. Data from medical records was collected to describe the clinical characteristics of the participants.</p>
</sec>
<sec id="sec10">
<label>2.4</label>
<title>Analysis</title>
<p>FGD sessions were transcribed verbatim and independently coded by two research team members using practical thematic analysis that uses both deductive and inductive analysis. Categories and themes were developed <italic>a priori</italic> based on the IBM constructs to create a structured categorization matrix. Inductive codes were also developed by the two members, who meet as a team regularly to review codes and ensure consistency in reaching a consensus collaboratively. The data was analyzed using thematic analysis. The steps Saunders et al. suggested to conduct a practical thematic analysis were followed (<xref ref-type="bibr" rid="ref31">31</xref>).</p>
<p>Statistical analysis was performed in the quantitative study phase using SPSS 20.0 Software. Descriptive statistics are presented in percentages, median, max and min values. The data from continuous variables (age, schooling, etc.) are presented as the median value plus the minimum and maximum values. Demographic data are presented as frequency and percentage. Quantitative and qualitative data were analyzed separately and compared to explore convergent and divergent results. The Good Reporting of a Mixed Methods Study (GRAMMS) guidelines were used to guide the reporting of this study (<xref ref-type="bibr" rid="ref31">31</xref>).</p>
</sec>
</sec>
<sec sec-type="results" id="sec11">
<label>3</label>
<title>Results</title>
<sec id="sec12">
<label>3.1</label>
<title>Quantitative findings</title>
<sec id="sec13">
<label>3.1.1</label>
<title>Survey participant characteristics</title>
<p>137 TB individuals with TB participated in the study, with 40 (<italic>n</italic>&#x202F;=&#x202F;29.2) in the National District and 97 (<italic>n</italic>&#x202F;=&#x202F;70.8) in Santo Domingo. Among the participants, 75 (54%) were male. Most survey participants identified as Dominican (<italic>n</italic>&#x202F;=&#x202F;133, 97.1%), three Haitians (<italic>n</italic>&#x202F;=&#x202F;3, 2.2%), and one Venezuelan (<italic>n</italic>&#x202F;=&#x202F;1, 0.7%). Most reported being single (<italic>n</italic>&#x202F;=&#x202F;78, 56.9%) and with a partner (<italic>n</italic>&#x202F;=&#x202F;47, 34.3%). Most participants reported literacy skills, with 97.1% (<italic>n</italic>&#x202F;=&#x202F;133) being able to read and write. Regarding education, 33% (<italic>n</italic>&#x202F;=&#x202F;45) had a primary school level, nearly 50% (<italic>n</italic>&#x202F;=&#x202F;69) completed secondary school, and 12% (<italic>n</italic>&#x202F;=&#x202F;16) attended university (<xref ref-type="table" rid="tab1">Table 1</xref>).</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Sociodemographic and clinical characteristics of the TB patients who were included in the study, Santo Domingo, 2019 (<italic>n</italic>&#x202F;=&#x202F;137).</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Variables</th>
<th align="center" valign="top"><italic>n</italic>&#x202F;=&#x202F;137</th>
<th align="center" valign="top">%</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top" colspan="3">Sex</td>
</tr>
<tr>
<td align="left" valign="top">Male<break/>Female</td>
<td align="center" valign="top">75</td>
<td align="center" valign="top">54.7</td>
</tr>
<tr>
<td align="left" valign="top" colspan="3">Province</td>
</tr>
<tr>
<td align="left" valign="top">Distrito Nacional</td>
<td align="center" valign="top">40</td>
<td align="center" valign="top">29.2</td>
</tr>
<tr>
<td align="left" valign="top">Santo Domingo</td>
<td align="center" valign="top">97</td>
<td align="center" valign="top">70.8</td>
</tr>
<tr>
<td align="left" valign="top">Age&#x2014;mean age (+&#x202F;&#x2212;&#x202F;SD)<break/>Age (in years)</td>
<td align="center" valign="top">xx</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">18&#x2013;24</td>
<td align="center" valign="middle">31</td>
<td align="center" valign="middle">22.63</td>
</tr>
<tr>
<td align="left" valign="middle">25&#x2013;34</td>
<td align="center" valign="middle">35</td>
<td align="center" valign="middle">25.55</td>
</tr>
<tr>
<td align="left" valign="middle">35&#x2013;44</td>
<td align="center" valign="middle">24</td>
<td align="center" valign="middle">17.52</td>
</tr>
<tr>
<td align="left" valign="middle">45&#x2013;54</td>
<td align="center" valign="middle">27</td>
<td align="center" valign="middle">19.71</td>
</tr>
<tr>
<td align="left" valign="middle">55&#x2013;64</td>
<td align="center" valign="middle">12</td>
<td align="center" valign="middle">8.76</td>
</tr>
<tr>
<td align="left" valign="middle">&#x003E;65</td>
<td align="center" valign="middle">8</td>
<td align="center" valign="middle">5.84</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="3">Nationality</td>
</tr>
<tr>
<td align="left" valign="top">Dominican</td>
<td align="center" valign="top">133</td>
<td align="center" valign="top">97.1</td>
</tr>
<tr>
<td align="left" valign="top">Haitian</td>
<td align="center" valign="top">3</td>
<td align="center" valign="middle">2.2</td>
</tr>
<tr>
<td align="left" valign="top">Venezuelan</td>
<td align="center" valign="top">1</td>
<td/>
</tr>
<tr>
<td align="left" valign="top" colspan="3">Schooling level</td>
</tr>
<tr>
<td align="left" valign="top">Primary school</td>
<td align="center" valign="top">50</td>
<td align="center" valign="top">35.5</td>
</tr>
<tr>
<td align="left" valign="top">Secondary school</td>
<td align="center" valign="top">66</td>
<td align="center" valign="top">48.2</td>
</tr>
<tr>
<td align="left" valign="top">University</td>
<td align="center" valign="top">18</td>
<td align="center" valign="top">13.1</td>
</tr>
<tr>
<td align="left" valign="top">None</td>
<td align="center" valign="top">3</td>
<td align="center" valign="top">2.2</td>
</tr>
<tr>
<td align="left" valign="top">Literacy (know how to read and write)</td>
<td align="center" valign="top">133</td>
<td align="center" valign="top">97.1</td>
</tr>
<tr>
<td align="left" valign="top" colspan="3">Place where the patients get the medication</td>
</tr>
<tr>
<td align="left" valign="top">At the healthcare center</td>
<td align="center" valign="top">127</td>
<td align="center" valign="top">92.7</td>
</tr>
<tr>
<td align="left" valign="top">At home</td>
<td align="center" valign="top">10</td>
<td align="center" valign="top">7.3</td>
</tr>
<tr>
<td align="left" valign="top" colspan="3">Clinical characteristics</td>
</tr>
<tr>
<td align="left" valign="top">Newly admitted patients</td>
<td align="center" valign="top">122</td>
<td align="center" valign="top">81.8</td>
</tr>
<tr>
<td align="left" valign="top">Patients recovered after dropout</td>
<td align="center" valign="top">10</td>
<td align="center" valign="top">7.3</td>
</tr>
<tr>
<td align="left" valign="top">Relapse</td>
<td align="center" valign="top">10</td>
<td align="center" valign="top">7.3</td>
</tr>
<tr>
<td align="left" valign="top">Previously treated patients</td>
<td align="center" valign="top">5</td>
<td align="center" valign="top">3.6</td>
</tr>
<tr>
<td align="left" valign="top">Mean time in the treatment (in month), M (SD)</td>
<td align="center" valign="top">4.7 (3.24)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Irregular or nonadherent</td>
<td align="center" valign="top">22</td>
<td align="center" valign="top">16.1</td>
</tr>
<tr>
<td align="left" valign="top" colspan="3">Comorbidities</td>
</tr>
<tr>
<td align="left" valign="top">Had at least one comorbidity</td>
<td align="center" valign="top">47</td>
<td align="center" valign="top">35.0</td>
</tr>
<tr>
<td align="left" valign="top">Diabetes Mellitus</td>
<td align="center" valign="top">16</td>
<td align="center" valign="top">11.6</td>
</tr>
<tr>
<td align="left" valign="top">HIV</td>
<td align="center" valign="top">15</td>
<td align="center" valign="top">10.9</td>
</tr>
<tr>
<td align="left" valign="top">Other</td>
<td align="center" valign="top">17</td>
<td align="center" valign="top">12.5</td>
</tr>
<tr>
<td align="left" valign="top" colspan="3">Substance use</td>
</tr>
<tr>
<td align="left" valign="top">Alcohol use</td>
<td align="center" valign="top">12</td>
<td align="center" valign="top">8.8</td>
</tr>
<tr>
<td align="left" valign="top">Tobacco use</td>
<td align="center" valign="top">8</td>
<td align="center" valign="top">5.8</td>
</tr>
<tr>
<td align="left" valign="top">Drugs use</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">1.5</td>
</tr>
<tr>
<td align="left" valign="top">Have a health insurance</td>
<td align="center" valign="top">117</td>
<td align="center" valign="top">85.4</td>
</tr>
<tr>
<td align="left" valign="top">Did an economic activity last week at least 1&#x202F;h (YES)</td>
<td align="center" valign="top">100</td>
<td align="center" valign="top">73.0</td>
</tr>
<tr>
<td align="left" valign="top">Before been treated, did you work before (YES)</td>
<td align="center" valign="top">102</td>
<td align="center" valign="top">74.5</td>
</tr>
<tr>
<td align="left" valign="top">Did you leave the work because of the disease (YES)</td>
<td align="center" valign="top">85</td>
<td align="center" valign="top">62.0</td>
</tr>
<tr>
<td align="left" valign="top">Did you experience a reduction on your income because of the disease</td>
<td align="center" valign="top">97</td>
<td align="center" valign="top">70.8</td>
</tr>
<tr>
<td align="left" valign="top">During the past 12&#x202F;months, was there ever a time when your household went without food due to lack of money or other resources? (YES)</td>
<td align="center" valign="top">86</td>
<td align="center" valign="top">62.8</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec14">
<label>3.1.2</label>
<title>Clinical characteristics</title>
<p>Predominantly, the participants were newly admitted patients (<italic>n</italic>&#x202F;=&#x202F;112, 81.8%), followed by those recovered after dropout (<italic>n</italic>&#x202F;=&#x202F;10, 7.3%), relapse (<italic>n</italic>&#x202F;=&#x202F;10, 7.3%), and previously treated patients (<italic>n</italic>&#x202F;=&#x202F;5, 3.6%). The mean treatment duration was 4.07&#x202F;months (SD: 3.27, mi<italic>n</italic>&#x202F;=&#x202F;1, max&#x202F;=&#x202F;24). A small percentage were healthcare workers (<italic>n</italic>&#x202F;=&#x202F;6, 4.3%). Over 90% attended the health center for medication, and 95% had not completed treatment in the past 3&#x202F;months. Patients who could not follow up represent 4.4% (<italic>n</italic>&#x202F;=&#x202F;6) and 12% (<italic>n</italic>&#x202F;=&#x202F;17) recovered. Approximately 63% (<italic>n</italic>&#x202F;=&#x202F;86.3) were self-administering the medication and supervised by video call, 27% (<italic>n</italic>&#x202F;=&#x202F;37) were self-administering the medication without supervision, 8% (<italic>n</italic>&#x202F;=&#x202F;10) reported recording a video, and 2.2% (<italic>n</italic>&#x202F;=&#x202F;3) attended the health center in person (<xref ref-type="table" rid="tab1">Table 1</xref>).</p>
</sec>
<sec id="sec15">
<label>3.1.3</label>
<title>The integrated behavioral model (IBM) categories</title>
<p>We summarized the results in this section. In <xref ref-type="table" rid="tab2">Table 2</xref> we integrate qualitative and quantitative data.</p>
<table-wrap position="float" id="tab2">
<label>Table 2</label>
<caption>
<p>Knowledge, attitudes, practices of individuals with TB related to the use of digital technologies for prevention and control, Santo Domingo, 2019 (<italic>n</italic>&#x202F;=&#x202F;137).</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Variables</th>
<th align="center" valign="top"><italic>n</italic>&#x202F;=&#x202F;137</th>
<th align="center" valign="top">%</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top" colspan="3">Know disease symptoms</td>
</tr>
<tr>
<td align="left" valign="top">Cough</td>
<td align="center" valign="top">100</td>
<td align="center" valign="top">73.0</td>
</tr>
<tr>
<td align="left" valign="top">Cold</td>
<td align="center" valign="top">64</td>
<td align="center" valign="top">46.7</td>
</tr>
<tr>
<td align="left" valign="top">Weight loss</td>
<td align="center" valign="top">35</td>
<td align="center" valign="top">25.5</td>
</tr>
<tr>
<td align="left" valign="top">General malaise</td>
<td align="center" valign="top">30</td>
<td align="center" valign="top">21.9</td>
</tr>
<tr>
<td align="left" valign="top">Chest pain</td>
<td align="center" valign="top">15</td>
<td align="center" valign="top">10.9</td>
</tr>
<tr>
<td align="left" valign="top">lack of appetite</td>
<td align="center" valign="top">25</td>
<td align="center" valign="top">18.2</td>
</tr>
<tr>
<td align="left" valign="top">Night sweats</td>
<td align="center" valign="top">19</td>
<td align="center" valign="top">13.9</td>
</tr>
<tr>
<td align="left" valign="top">Weakness or fatigue</td>
<td align="center" valign="top">18</td>
<td align="center" valign="top">13.1</td>
</tr>
<tr>
<td align="left" valign="top">Shivers</td>
<td align="center" valign="top">18</td>
<td align="center" valign="top">13.1</td>
</tr>
<tr>
<td align="left" valign="top">Phlegm</td>
<td align="center" valign="top">17</td>
<td align="center" valign="top">12.4</td>
</tr>
<tr>
<td align="left" valign="top">Know if the disease can be cured</td>
<td align="center" valign="top">133</td>
<td align="center" valign="top">97.1</td>
</tr>
<tr>
<td align="left" valign="top" colspan="3">Knows how to cure</td>
</tr>
<tr>
<td align="left" valign="top">With pills delivered to the health center (self-administered)</td>
<td align="center" valign="top">111</td>
<td align="center" valign="top">81.0</td>
</tr>
<tr>
<td align="left" valign="top">With pills that are taken under the supervision of health personnel</td>
<td align="center" valign="top">23</td>
<td align="center" valign="top">16.8</td>
</tr>
<tr>
<td align="left" valign="top">Resting at home</td>
<td align="center" valign="top">12</td>
<td align="center" valign="top">8.8</td>
</tr>
<tr>
<td align="left" valign="top">Taking natural or home remedies</td>
<td align="center" valign="top">9</td>
<td align="center" valign="top">6.6</td>
</tr>
<tr>
<td align="left" valign="top" colspan="3">What makes a person not healed?</td>
</tr>
<tr>
<td align="left" valign="top">When you do not take the medicine daily</td>
<td align="center" valign="top">135</td>
<td align="center" valign="top">98.5</td>
</tr>
<tr>
<td align="left" valign="top">When you do not rest</td>
<td align="center" valign="top">20</td>
<td align="center" valign="top">14.6</td>
</tr>
<tr>
<td align="left" valign="top">When you do not pray</td>
<td align="center" valign="top">3</td>
<td align="center" valign="top">2.2</td>
</tr>
<tr>
<td align="left" valign="top">When you do not eat well</td>
<td align="center" valign="top">20</td>
<td align="center" valign="top">14.6</td>
</tr>
<tr>
<td align="left" valign="top">When you drink alcohol</td>
<td align="center" valign="top">24</td>
<td align="center" valign="top">17.5</td>
</tr>
<tr>
<td align="left" valign="top">When you use drugs (juka)</td>
<td align="center" valign="top">18</td>
<td align="center" valign="top">13.1</td>
</tr>
<tr>
<td align="left" valign="top">Cellphone can be utilized for healthcare purpose</td>
<td align="center" valign="top">124</td>
<td align="center" valign="top">90.5</td>
</tr>
<tr>
<td align="left" valign="top" colspan="3">Know how to use basic features of mobile phones</td>
</tr>
<tr>
<td align="left" valign="top">Sending and receiving text messages (SMSs)</td>
<td align="center" valign="top">96</td>
<td align="center" valign="top">70.1</td>
</tr>
<tr>
<td align="left" valign="top">Sending and receiving voice messages</td>
<td align="center" valign="top">24</td>
<td align="center" valign="top">17.5</td>
</tr>
<tr>
<td align="left" valign="top">Making phone calls</td>
<td align="center" valign="top">19</td>
<td align="center" valign="top">13.9</td>
</tr>
<tr>
<td align="left" valign="top">Making video calls</td>
<td align="center" valign="top">17</td>
<td align="center" valign="top">12.4</td>
</tr>
<tr>
<td align="left" valign="top">Using WhatsApp or other chat</td>
<td align="center" valign="top">17</td>
<td align="center" valign="top">12.4</td>
</tr>
<tr>
<td align="left" valign="top">Receiving a reminder of their appointments</td>
<td align="center" valign="top">9</td>
<td align="center" valign="top">6.6</td>
</tr>
<tr>
<td align="left" valign="top">As medication monitoring (reminder treatments)</td>
<td align="center" valign="top">11</td>
<td align="center" valign="top">8.0</td>
</tr>
<tr>
<td align="left" valign="top" colspan="3">Did you feel well-informed about TB?</td>
</tr>
<tr>
<td align="left" valign="top">Strongly disagree</td>
<td align="center" valign="top">44</td>
<td align="center" valign="top">32.1</td>
</tr>
<tr>
<td align="left" valign="top">Disagree</td>
<td align="center" valign="top">56</td>
<td align="center" valign="top">40.9</td>
</tr>
<tr>
<td align="left" valign="top">Neither agree nor disagree</td>
<td align="center" valign="top">16</td>
<td align="center" valign="top">11.7</td>
</tr>
<tr>
<td align="left" valign="top">Agree</td>
<td align="center" valign="top">18</td>
<td align="center" valign="top">13.1</td>
</tr>
<tr>
<td align="left" valign="top">Strongly agree</td>
<td align="center" valign="top">3</td>
<td align="center" valign="top">2.2</td>
</tr>
<tr>
<td align="left" valign="top">Would like to receive health-related text messages over the phone regarding how to keep healthy? (Yes)</td>
<td align="center" valign="top">115</td>
<td align="center" valign="top">83.9</td>
</tr>
<tr>
<td align="left" valign="top" colspan="3">Would like to receive reminders over the phone about when to take TB treatment?</td>
</tr>
<tr>
<td align="left" valign="top">Absolutely appropriate</td>
<td align="center" valign="top">56</td>
<td align="center" valign="top">40.9</td>
</tr>
<tr>
<td align="left" valign="top">Appropriate</td>
<td align="center" valign="top">69</td>
<td align="center" valign="top">50.4</td>
</tr>
<tr>
<td align="left" valign="top">Neutral</td>
<td align="center" valign="top">4</td>
<td align="center" valign="top">2.9</td>
</tr>
<tr>
<td align="left" valign="top">Inappropriate</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">1.5</td>
</tr>
<tr>
<td align="left" valign="top">Absolutely inappropriate</td>
<td align="center" valign="top">6</td>
<td align="center" valign="top">4.4</td>
</tr>
<tr>
<td align="left" valign="middle" colspan="3">Preference on follow-up by providers for treatment adherence monitoring</td>
</tr>
<tr>
<td align="left" valign="top">Visiting the TB unit</td>
<td align="center" valign="top">35</td>
<td align="center" valign="top">25.5</td>
</tr>
<tr>
<td align="left" valign="top">Supervision at home by the health promotor</td>
<td align="center" valign="top">48</td>
<td align="center" valign="top">35.0</td>
</tr>
<tr>
<td align="left" valign="top">Supervision at home by a family member</td>
<td align="center" valign="top">15</td>
<td align="center" valign="top">10.9</td>
</tr>
<tr>
<td align="left" valign="middle">Sending daily a voice message</td>
<td align="center" valign="top">14</td>
<td align="center" valign="top">10.2</td>
</tr>
<tr>
<td align="left" valign="middle">Sending daily a text message</td>
<td align="center" valign="top">4</td>
<td align="center" valign="top">2.9</td>
</tr>
<tr>
<td align="left" valign="middle">Record a video and send it to health personnel</td>
<td align="center" valign="top">10</td>
<td align="center" valign="top">7.3</td>
</tr>
<tr>
<td align="left" valign="middle">Make a video call with provider</td>
<td align="center" valign="top">7</td>
<td align="center" valign="top">5.1</td>
</tr>
<tr>
<td align="left" valign="middle">Other</td>
<td align="center" valign="top">4</td>
<td align="center" valign="top">2.9</td>
</tr>
<tr>
<td align="left" valign="middle" colspan="3">Fear of loss of privacy by utilizing WhatsApp or sending recorded videos to providers</td>
</tr>
<tr>
<td align="left" valign="middle">Very untrue of me</td>
<td align="center" valign="top">4</td>
<td align="center" valign="top">2.9</td>
</tr>
<tr>
<td align="left" valign="middle">Untrue of me</td>
<td align="center" valign="top">5</td>
<td align="center" valign="top">3.6</td>
</tr>
<tr>
<td align="left" valign="middle">Neutral</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">1.5</td>
</tr>
<tr>
<td align="left" valign="middle">True of me</td>
<td align="center" valign="top">3</td>
<td align="center" valign="top">2.2</td>
</tr>
<tr>
<td align="left" valign="middle">Very true of me</td>
<td align="center" valign="top">123</td>
<td align="center" valign="top">89.8</td>
</tr>
<tr>
<td align="left" valign="middle">Preference for using a mobile app (different from WhatsApp) that is more private and confidential for follow-up by providers</td>
<td align="center" valign="top">74</td>
<td align="center" valign="top">54</td>
</tr>
<tr>
<td align="left" valign="middle">Practices: Reported having a personal cell phone.</td>
<td align="center" valign="top">121</td>
<td align="center" valign="top">88.3</td>
</tr>
<tr>
<td align="left" valign="middle" colspan="3">Had used their phones</td>
</tr>
<tr>
<td align="left" valign="middle">Several times a day</td>
<td align="center" valign="top">119</td>
<td align="center" valign="top">86.9</td>
</tr>
<tr>
<td align="left" valign="middle">Used it only once today or in the last 24&#x202F;h</td>
<td align="center" valign="top">3</td>
<td align="center" valign="top">2.2</td>
</tr>
<tr>
<td align="left" valign="middle">They do not currently use it.</td>
<td align="center" valign="top">15</td>
<td align="center" valign="top">10.9</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="3">Purposes of smartphone use</td>
</tr>
<tr>
<td align="left" valign="bottom">Chatting (WhatsApp)</td>
<td align="center" valign="top">68</td>
<td align="center" valign="top">49.6</td>
</tr>
<tr>
<td align="left" valign="bottom">Social networks (Facebook, Twitter)</td>
<td align="center" valign="top">30</td>
<td align="center" valign="top">21.9</td>
</tr>
<tr>
<td align="left" valign="bottom">Personal calls</td>
<td align="center" valign="top">86</td>
<td align="center" valign="top">62.8</td>
</tr>
<tr>
<td align="left" valign="bottom">Work calls</td>
<td align="center" valign="top">14</td>
<td align="center" valign="top">10.2</td>
</tr>
<tr>
<td align="left" valign="bottom">Search of products and services</td>
<td align="center" valign="top">8</td>
<td align="center" valign="top">5.8</td>
</tr>
<tr>
<td align="left" valign="bottom">Buy at pharmacies, shopping malls, others</td>
<td align="center" valign="top">9</td>
<td align="center" valign="top">6.6</td>
</tr>
<tr>
<td align="left" valign="bottom">As an alarm clock</td>
<td align="center" valign="top">7</td>
<td align="center" valign="top">5.1</td>
</tr>
<tr>
<td align="left" valign="top" colspan="3">Most difficult regarding taking pills (TB treatment)</td>
</tr>
<tr>
<td align="left" valign="top">Adverse effects</td>
<td align="center" valign="top">84</td>
<td align="center" valign="top">61.3</td>
</tr>
<tr>
<td align="left" valign="top">Having something to eat before</td>
<td align="center" valign="top">36</td>
<td align="center" valign="top">26.3</td>
</tr>
<tr>
<td align="left" valign="top">Taking it everyday</td>
<td align="center" valign="top">10</td>
<td align="center" valign="top">7.3</td>
</tr>
<tr>
<td align="left" valign="top">Comply with an schedule / time</td>
<td align="center" valign="top">17</td>
<td align="center" valign="top">12.4</td>
</tr>
<tr>
<td align="left" valign="top">Remind it&#x2014;always forget</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">1.5</td>
</tr>
<tr>
<td align="left" valign="top">My work</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0.7</td>
</tr>
</tbody>
</table>
</table-wrap>
<sec id="sec16">
<label>3.1.3.1</label>
<title>Knowledge</title>
<p>Most participants recognized cough (73.0%, <italic>n</italic>&#x202F;=&#x202F;100) as a disease symptom. Other symptoms were less known such as cold (46.7%, <italic>n</italic>&#x202F;=&#x202F;64), weight loss (25.5%, <italic>n</italic>&#x202F;=&#x202F;35), phlegm (12.4%, <italic>n</italic>&#x202F;=&#x202F;17), shivers (13.1%, <italic>n</italic>&#x202F;=&#x202F;18), fatigue (13.1%, <italic>n</italic>&#x202F;=&#x202F;18). Most (97.1%, <italic>n</italic>&#x202F;=&#x202F;133) know the disease can be cured. Of those, 81.0% (<italic>n</italic>&#x202F;=&#x202F;111) believe it is cured with pills from the health center (self-administered), 16.8% (<italic>n</italic>&#x202F;=&#x202F;23) mention that pills should be taken under medical supervision. Some mention resting (8.8%, <italic>n</italic>&#x202F;=&#x202F;12) and natural or home remedies (6.6%, <italic>n</italic>&#x202F;=&#x202F;9). Concerning factors preventing recovery, 98.5% (<italic>n</italic>&#x202F;=&#x202F;135) believe that not taking medicine daily is the main reason. Other factors mentioned include alcohol consumption (17.5%, <italic>n</italic>&#x202F;=&#x202F;24), poor nutrition (14.6%, <italic>n</italic>&#x202F;=&#x202F;20), lack of rest (14.6%, <italic>n</italic>&#x202F;=&#x202F;20), and drug use (13.1%, <italic>n</italic>&#x202F;=&#x202F;18). Only 2.2% (<italic>n</italic>&#x202F;=&#x202F;3) believe that lack of prayer affects healing. <xref ref-type="table" rid="tab2">Table 2</xref> shows descriptive data on knowledge questions.</p>
</sec>
<sec id="sec17">
<label>3.1.3.2</label>
<title>Attitudes</title>
<p>The majority, 90.5% (<italic>n</italic>&#x202F;=&#x202F;124), understood that a cell phone can be utilized for healthcare purposes. Receiving health-related text messages was highly rated as potentially helpful (84%). Most participants found it appropriate (<italic>n</italic>&#x202F;=&#x202F;69, 50.4%) or very appropriate (<italic>n</italic>&#x202F;=&#x202F;56, 40.9%) to receive reminders about their TB treatment on their phone. Regarding their level of information about TB, only 32.1% (<italic>n</italic>&#x202F;=&#x202F;44) felt &#x2018;very informed&#x2019;, (40.9%, <italic>n</italic>&#x202F;=&#x202F;56), while others ranged from somewhat informed (<italic>n</italic>&#x202F;=&#x202F;16, 11.7%), &#x2018;little informed&#x2019; (13.1%, <italic>n</italic>&#x202F;=&#x202F;18), to &#x2018;not at all informed&#x2019; (<italic>n</italic>&#x202F;=&#x202F;3, 2.1%). Nearly all users understand the importance of taking medication daily to cure the disease (<xref ref-type="table" rid="tab3">Table 3</xref>).</p>
<table-wrap position="float" id="tab3">
<label>Table 3</label>
<caption>
<p>Merge results from quantitative and qualitative analysis of IBM variables measured in individuals with TB, Santo Domingo, 2019.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Qualitative results</th>
<th align="left" valign="top">Quantitative results</th>
<th align="left" valign="top">Merge/integrating results</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Knowledge about digital health<break/><list list-type="bullet">
<list-item>
<p>Knowledge about how technology could be useful for health purposes.</p>
</list-item>
</list></td>
<td align="left" valign="top">Knowledge about mobile health<break/><list list-type="bullet">
<list-item>
<p>Limited understanding of TB symptoms</p>
</list-item>
<list-item>
<p>Only 16% knew that medication intake must be under health personnel supervision.</p>
</list-item>
<list-item>
<p>Participants considered resting at home (12.0, 9%) and traditional remedies (9.0, 7%) were healing methods.</p>
</list-item>
<list-item>
<p>About 13% ignored treatment duration.</p>
</list-item>
</list></td>
<td align="left" valign="top">
<list list-type="bullet">
<list-item>
<p>Most patients have basic knowledge of the use of mobile phones.</p>
</list-item>
<list-item>
<p>There is a need to close the knowledge gap and misconceptions.</p>
</list-item>
<list-item>
<p>Secure sources of information were not mentioned.</p>
</list-item>
</list>
</td>
</tr>
<tr>
<td align="left" valign="top"><list list-type="bullet">
<list-item>
<p><italic>Positive attitudes</italic> toward remote patient monitoring</p>
</list-item>
<list-item>
<p>Recognition of the benefits of treatment and digital health (instrumental&#x2014;cognitive attitude).</p>
</list-item>
<list-item>
<p>It is a relief to not have to attend the program in person.</p>
</list-item>
<list-item>
<p>Not worried about using mobile phones for treatment monitoring (experiential&#x2014;affective attitude)</p>
</list-item>
<list-item>
<p>Not being scared about the potential risk of harm due to loss of privacy.</p>
</list-item>
</list><italic>Negative attitudes</italic> toward remote monitoring as a daily activity, a patient manifested that he could send one or two videos per week but not daily.<break/>Descriptive norm<break/>A patient will commit to sending videos if the doctor requests it. <italic>&#x201C;If they tell me to send a video taking the pill, from now on I will send it&#x201D; (FGD 2, male, Participant #1).</italic></td>
<td align="left" valign="top">Attitudes<break/><list list-type="bullet">
<list-item>
<p>Only 40% reported feeling well informed about TB.</p>
</list-item>
<list-item>
<p>84% rated it as potentially helpful to receive text messages about how to improve their health.</p>
</list-item>
<list-item>
<p>Most participants consider it appropriate to use their mobile phones to receive reminders about medications.</p>
</list-item>
<list-item>
<p>90% indicated they were not concerned about the loss of privacy when using the internet to send recorded videos to health personnel.</p>
</list-item>
<list-item>
<p>More than 50% would prefer to use an alternative application to WhatsApp.</p>
</list-item>
</list></td>
<td align="left" valign="top">Responses in both qualitative and quantitative methods were coherent.<break/><list list-type="bullet">
<list-item>
<p>Considering they are not well informed regarding the disease</p>
</list-item>
<list-item>
<p>Having positive attitudes toward technology because they see the benefits.</p>
</list-item>
<list-item>
<p>Not be concerned with loss of privacy</p>
</list-item>
<list-item>
<p>Positive about using a mobile App for remote monitoring</p>
</list-item>
</list></td>
</tr>
<tr>
<td align="left" valign="top">Behavioral importance (Theme 7), The phone is a valuable tool for communication.<break/><italic>&#x2018;The phone would help me a lot because that way I can communicate with you&#x201D; (FGD 1, female, Participant #2).</italic></td>
<td align="left" valign="top">124 (90.5%) participants understand mobile phones can be used for health care.</td>
<td align="left" valign="top">Technologies used for health are a valuable tool.</td>
</tr>
<tr>
<td align="left" valign="top">Practices<break/>Previous experience with similar technologies.<break/>Self-efficacy<break/>Participants recorded themselves taking medications and sharing them with doctors.<break/>Personal agency -perceived self-control<break/><list list-type="bullet">
<list-item>
<p>Participants understand they are responsible for their health.</p>
</list-item>
<list-item>
<p>
<italic>&#x2018;I tell him: doctor, I am taking my medication&#x2019; (FGD 1, Participant #2)</italic>
</p>
</list-item>
</list></td>
<td align="left" valign="top">Practices<break/>90% reported having a mobile phone for personal use. 70.0% (<italic>n</italic> =&#x202F;96) use basic features.<break/>Taking medications<break/><list list-type="bullet">
<list-item>
<p>21.0% (<italic>n</italic> =&#x202F;29) said that they had stopped taking medication at some point during their treatment.</p>
</list-item>
<list-item>
<p>5.0% (<italic>n</italic> =&#x202F;7) reported having stopped taking medication for a week or more.</p>
</list-item>
</list></td>
<td align="left" valign="top">Qualitative and quantitative data confirmed that patients<break/><list list-type="bullet">
<list-item>
<p>do have access to mobile phones and the internet.</p>
</list-item>
<list-item>
<p>reported using basic functions such as calls, video calls, WhatsApp, etc.</p>
</list-item>
<list-item>
<p>reported having used a mobile phone for medical purposes.</p>
</list-item>
</list></td>
</tr>
<tr>
<td align="left" valign="top">Perceived facilitators (Theme 7)<break/><list list-type="bullet">
<list-item>
<p>Mobile phones facilitate healthcare providers and patient communication and monitoring.</p>
</list-item>
<list-item>
<p>
<italic>&#x201C;I have it, I use it, mobile phones are very important for everything, in this case &#x2026; she [the nurse] calls me when I have to come to the unit&#x201D; (FGD 1 Participant #1).</italic>
</p>
</list-item>
</list></td>
<td align="left" valign="top">Access to the internet in the last 3&#x202F;months<break/><list list-type="bullet">
<list-item>
<p>98% claimed that they accessed the Internet from home.</p>
</list-item>
</list></td>
<td align="left" valign="top">
<list list-type="bullet">
<list-item>
<p>Internet access could improve communication between health personnel and patients.</p>
</list-item>
</list>
</td>
</tr>
<tr>
<td align="left" valign="top">Perceived barriers (Theme 8)<break/><list list-type="bullet">
<list-item>
<p>Lack of cell phone or mobile device.</p>
</list-item>
<list-item>
<p>Limited internet access due to cost.</p>
</list-item>
<list-item>
<p>
<italic>&#x201C;I do not have one [a mobile phone]&#x201D; (FGD 2 Participant #2). &#x2018;Now I have the chip cut off because I have not paid it, (FGD 1 Participant #4).</italic>
</p>
</list-item>
<list-item>
<p>Lack of health insurance and social assistance programs.</p>
</list-item>
</list></td>
<td align="left" valign="top">Perceived barriers<break/><list list-type="bullet">
<list-item>
<p>The most challenging aspect of maintaining adherence was the medication&#x2019;s adverse effects.</p>
</list-item>
</list></td>
<td align="left" valign="top">
<list list-type="bullet">
<list-item>
<p>Lack of a digital device, limited access to the Internet, or limited experience using cell phone functionalities and the adverse effects were barriers to patient adherence.</p>
</list-item>
</list>
</td>
</tr>
<tr>
<td align="left" valign="top">Patient preferences<break/><list list-type="bullet">
<list-item>
<p>Patients might have a preferred treatment schedule or communication way. &#x2018;I do not like to take the pill in the morning because it is heavy. I believe that the important thing is to take it&#x2019; (FGD 1 Participant #2).</p>
</list-item>
</list></td>
<td align="left" valign="top">Patient preferences<break/><list list-type="bullet">
<list-item>
<p>35.0% (<italic>n</italic> =&#x202F;48) reported preferring health promoters supervise treatment compliance, (7.3%, <italic>n</italic> =&#x202F;10) send a voice message daily or record a video and send it to the health personnel, (5.1%, <italic>n</italic> =&#x202F;7) make a daily video call.</p>
</list-item>
</list></td>
<td align="left" valign="top">
<list list-type="bullet">
<list-item>
<p>Patients have preferences regarding how, where, and when to take the medication and be monitored.</p>
</list-item>
</list>
</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec18">
<label>3.1.3.3</label>
<title>Practices</title>
<p>A significant majority, 89.8% (<italic>n</italic>&#x202F;=&#x202F;123) reported having a personal cell phone. Most participants, 86.9% (<italic>n</italic>&#x202F;=&#x202F;119), used their phones several times a day, 2.2% (<italic>n</italic>&#x202F;=&#x202F;3) said they used it only once today or in the last 24&#x202F;h, while 10.2% (<italic>n</italic>&#x202F;=&#x202F;14) responded that they do not currently use it. Basic features such as sending and receiving text messages were commonly used (<italic>n</italic>&#x202F;=&#x202F;96, 70%). About 63% (<italic>n</italic>&#x202F;=&#x202F;86) used their phones for personal calls, and half of them used it for chatting (WhatsApp), 23% (<italic>n</italic>&#x202F;=&#x202F;32) for social networks (Facebook, Twitter), 10% (<italic>n</italic>&#x202F;=&#x202F;14) for work calls, 6.6% (<italic>n</italic>&#x202F;=&#x202F;9) for shopping, and 5% (<italic>n</italic>&#x202F;=&#x202F;7) as an alarm clock. Having internet access from home in the last 3&#x202F;months was reported by 98% (<italic>n</italic>&#x202F;=&#x202F;123). Few reported using mobile phones as a reminder of their appointments or medication monitoring (<italic>n</italic>&#x202F;=&#x202F;11, 8%).</p>
</sec>
</sec>
<sec id="sec19">
<label>3.1.4</label>
<title>Clinical and adherence characteristics</title>
<p>According to medical records, 16.1% (<italic>n</italic>&#x202F;=&#x202F;22) of participants were irregular or nonadherent to treatment. 35% of participants had at least one comorbidity, with diabetes (11.6%, <italic>n</italic>&#x202F;=&#x202F;16) and HIV (10.9%, <italic>n</italic>&#x202F;=&#x202F;15) being the most frequent. Participants reported substance use: alcohol use (8.8%, <italic>n</italic>&#x202F;=&#x202F;12), tobacco use (5.8%, <italic>n</italic>&#x202F;=&#x202F;8), and drugs (1.5%, <italic>n</italic>&#x202F;=&#x202F;2).</p>
</sec>
</sec>
<sec id="sec20">
<label>3.2</label>
<title>Qualitative findings</title>
<p>Nine patients participated in the FGDs: the first group comprised 6 users (4 men, 2 women), with ages ranging from 19 to 56 (mean 35.2), and the second group included 3 men, with ages ranging from 23 to 60 (mean 40.6). Participants had a low socioeconomic status, and the level of education was primary. Every week or every 2&#x202F;weeks, they pick up the medications as scheduled by the team. The qualitative findings centered on eight core themes from IBM. Exemplars for each theme are presented in <xref ref-type="table" rid="tab2">Table 2</xref>.</p>
<sec id="sec21">
<label>3.2.1</label>
<title>Theme 1&#x2014;knowledge</title>
<p>This theme encompassed two categories: <italic>knowledge about digital tools and knowledge about TB as a disease.</italic> Participants described a lack of information about TB and basic knowledge about digital tools. <italic>&#x201C;For me, it is important [access to technology] because at the beginning of the disease [TB] one does not know anything&#x201D; (FGD 1 Participant #1).</italic></p>
</sec>
<sec id="sec22">
<label>3.2.2</label>
<title>Theme 2&#x2014;experiential and instrumental attitudes</title>
<p>Participants reported not being concerned about using their cell phones for communication and treatment monitoring (experiential-affective attitude). They recognized the benefits of treatment and using digital health tools (instrumental-cognitive attitude). <italic>&#x2018;The doctor told me like [sic] I was not taking the pill, but I take it during the week, and I said: &#x201C;no, but I&#x2019;ll make a video for you so you can see me taking it&#x201D;&#x2019; (FGD 1 Participant #4).</italic></p>
</sec>
<sec id="sec23">
<label>3.2.3</label>
<title>Theme 3&#x2014;Perceived norm</title>
<p>Participants expressed the need to demonstrate their treatment compliance by sending videos or calling health personnel. Some participants noted they would only send a video if requested explicitly by the doctor (injunctive norm&#x2014;what others expect them to do -). <italic>&#x201C;If they tell me to send a video taking the pill, from now on I will send it&#x201D; (FGD 2, male, Participant #1).</italic></p>
</sec>
<sec id="sec24">
<label>3.2.4</label>
<title>Theme 4&#x2014;personal agency</title>
<p>Comments reflected perceived self-control and self-efficacy. <italic>&#x2018;I tell him: doctor, I am taking my medication&#x2019; (FGD 1, Participant #2). &#x2018;I was at a party, yes, but now I am ready for my thing again [to re-start medication]&#x2019; (FGD 2 Participant #1).</italic></p>
</sec>
<sec id="sec25">
<label>3.2.5</label>
<title>Theme 5&#x2014;practices</title>
<p>This theme included participants&#x2019; familiarity and proficiency in <italic>using technology</italic> and <italic>taking medication</italic>. Participants responded as if it were obvious that they knew how to use &#x201C;technology&#x201D; (cell phones), popular apps, and social media. <italic>&#x2018;I use WhatsApp, Facebook, and Instagram.&#x2019; (FGD 1 Participant #4).</italic></p>
</sec>
<sec id="sec26">
<label>3.2.6</label>
<title>Theme 6&#x2014;facilitators</title>
<p>Participants generally perceived mobile devices as facilitators that allow interaction with health personnel. <italic>&#x201C;I have it, I use it, mobile phones are very important for everything, in this case &#x2026; she [the nurse] calls me when I have to come to the unit&#x201D; (FGD 1 Participant #1).</italic></p>
</sec>
<sec id="sec27">
<label>3.2.7</label>
<title>Theme 7&#x2014;importance of the behavior</title>
<p>Mobile devices are considered necessary, particularly as reminders and communication channels. <italic>&#x2018;The phone would help me a lot because that way I can communicate with you&#x201D; (FGD 1, female, Participant #2).</italic></p>
</sec>
<sec id="sec28">
<label>3.2.8</label>
<title>Theme 8&#x2014;perceived barriers</title>
<p>Perceived barriers were associated with the lack of a digital device, limited internet access, or limited experience using cell phone functionalities (e.g., social networks and video calls). Barriers to treatment adherence also included patient preferences regarding the time to take the medication, lack of health insurance, and participation in government assistance programs. <italic>&#x201C;I do not have one [a mobile phone]&#x201D; (FGD 2 Participant #2). &#x2018;Now I have the chip cut off because I have not paid it, (FGD 1 Participant #4)</italic>.</p>
</sec>
</sec>
<sec id="sec29">
<label>3.3</label>
<title>Integrating phase</title>
<p>Quantitative data showed a limited understanding of basic aspects of the disease, and qualitative data confirmed the importance that participants place on digital health. Positive attitudes were identified toward being remotely monitored, receiving text messages, and using their phones for health purposes. Also, they stated that they do not have privacy concerns or are scared about the potential risks of losing privacy while using digital technologies. Key findings for the IBM variables are presented in <xref ref-type="table" rid="tab3">Table 3</xref>.</p>
</sec>
</sec>
<sec sec-type="discussion" id="sec30">
<label>4</label>
<title>Discussion</title>
<p>This study aimed to describe patients&#x2019; attitudes and behaviors digital technologies for TB control and prevention. According to medical records and patient reports in the study, 16.1% of the patients showed irregular medication taking. This aligns with the National TB Program&#x2019;s Annual Report 2020 findings, which reported that 11 to 25% of patients were lost to follow-up treatment, depending on their clinical and sociodemographic characteristics (<xref ref-type="bibr" rid="ref23">23</xref>). However, the percentage of non-adherence to treatment may be even higher in this population. Unfortunately, the report did not provide a specific indicator for treatment adherence. Participants in the study showed a knowledge gap (e.g., only 16% knew the importance of DOT) and expressed a desire for more information about TB and its treatment. This situation partially explains the high rate of lost follow-up and irregular medication taking. A qualitative study of KAP towards TB in Georgia revealed good knowledge among current and former TB patients (<xref ref-type="bibr" rid="ref32">32</xref>). Consistent with other studies, we found that patients can learn about their condition (<xref ref-type="bibr" rid="ref33">33</xref>).</p>
<p>Participants expressed a positive attitude towards the benefits of using digital technology for communication with health personnel to support taking treatment and remaining adherent, dispelling fears of privacy loss. Most participants (<italic>n</italic>&#x202F;=&#x202F;69, 50.4%) wanted to receive text messages providing health tips and reminders. Several other studies have attempted to evaluate evidence for the efficacy of various DAT interventions such as texting, Short Message Service (SMS) reminders, and mobile phone Apps, among other resources, at improving treatment adherence. Different studies have identified modest or no efficacy of SMS in improving treatment adherence (<xref ref-type="bibr" rid="ref34 ref35 ref36">34&#x2013;36</xref>), while other programs using interactive SMS (<xref ref-type="bibr" rid="ref14">14</xref>, <xref ref-type="bibr" rid="ref15">15</xref>) have proven effective in enhancing medication adherence (<xref ref-type="bibr" rid="ref16">16</xref>).</p>
<p>Iribarren et al. used the Information-Motivation-Behavioral Skills model to design and document the development of the intervention with a multidisciplinary team of researchers, clinicians, administrators, and patients in active TB treatment (<xref ref-type="bibr" rid="ref37">37</xref>). In the DR, we used an Integrative Behavioral Model to develop a DAT that is informed by a health behavior model that has been found successful at improving health-related behaviors (<xref ref-type="bibr" rid="ref28">28</xref>).</p>
<p>Participants reported using avoidance strategies, eluding thinking &#x2018;negative things&#x2019; about the disease and focusing on positive aspects of treatment (such as taking medication to get well-perceived self-management). Patients&#x2019; may have an interest to demonstrate compliance with treatment as perceived norm on how they should behave as users of the healthcare services. These aspects emphasize the need for tailored text messages supporting self-regulation (<xref ref-type="bibr" rid="ref16">16</xref>) helping them on how to avoid negative thoughts as the integrative model of behavioral prediction can be used for this purpose (<xref ref-type="bibr" rid="ref38">38</xref>).</p>
<p>Environmental barriers, such as limited access to digital devices and the internet, were identified in low- and middle-income countries (<xref ref-type="bibr" rid="ref17 ref18 ref19">17&#x2013;19</xref>). Cost considerations, particularly the affordability of cell phone services, pose challenges. The average monthly mobile phone plan exceeds the purchasing power of low-income families, as most often people with TB fall into this category. When writing this report, the average low-income family makes less than $675 per month, whereas the average monthly mobile phone plan is $55.00 (<xref ref-type="bibr" rid="ref39">39</xref>). Mobile phones are needed in order to use health apps that have been proved to be effective for scheduled follow-up visits and improves the probability of follow-up, reducing missing appointments and optimizing patient outcomes (<xref ref-type="bibr" rid="ref40">40</xref>). So, improving access to technology to patients can be recommended for low-income TB patients in the DR.</p>
<p>Behavioral models have been effectively applied in TB treatment adherence studies using mobile applications (<xref ref-type="bibr" rid="ref37">37</xref>, <xref ref-type="bibr" rid="ref41 ref42 ref43">41&#x2013;43</xref>), and similar models have demonstrated success in understanding TB prevention and treatment (<xref ref-type="bibr" rid="ref15">15</xref>). In a literature review of articles published between 1995 and 2015 on text messaging and mobile phone apps with adherence or compliance and youth/adolescents, only 32% of the identified studies incorporated a theoretical framework in their design (<xref ref-type="bibr" rid="ref36">36</xref>). Our study was driven by a theoretical model that can be further reviewed, analyzed, or improved for advancing health behavior science.</p>
<sec id="sec31">
<label>4.1</label>
<title>Limitations</title>
<p>Data collection occurred during the COVID-19 pandemic in December 2020, potentially influencing participant perspectives. The low number of participants in the FGDs and the need to scrutinize psychometric properties within the IBM constructs should be considered.</p>
<p>The COVID-19 pandemic restrictions impacted the number of patients visiting healthcare services and the number of patients who could be invited to the clinics. Therefore, small numbers were invited to the FGD sessions for safety measures and to comply with guidelines.</p>
</sec>
<sec id="sec32">
<label>4.2</label>
<title>Conclusions and recommendations</title>
<p>Findings highlight a digital divide, with some users preferring traditional healthcare visits. Interventions should consider patients&#x2019; preferences rather than impose new modalities. As most participants already use mobile phones to communicate with healthcare personnel, a VOT intervention is feasible.</p>
</sec>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="sec33">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec sec-type="ethics-statement" id="sec34">
<title>Ethics statement</title>
<p>The studies involving humans were approved by Comit&#x00E9; de &#x00C9;tica de Investigaci&#x00F3;n CENISMI. The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation in this study was provided by the participants&#x2019; legal guardians/next of kin.</p>
</sec>
<sec sec-type="author-contributions" id="sec35">
<title>Author contributions</title>
<p>JC-G: Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. RE-M: Conceptualization, Funding acquisition, Methodology, Writing &#x2013; review &#x0026; editing. EM: Data curation, Formal analysis, Investigation, Software, Writing &#x2013; review &#x0026; editing. LA: Investigation, Writing &#x2013; review &#x0026; editing, Formal analysis, Writing &#x2013; original draft. RE: Writing &#x2013; review &#x0026; editing, Investigation, Supervision. JB: Writing &#x2013; review &#x0026; editing, Project administration. SI: Conceptualization, Formal analysis, Methodology, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec sec-type="funding-information" id="sec36">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. This study was funded by the Research Fund of the Ministry of Higher Education and Technology FONDOCyT (Grant No. 2018-2019-3A7-214) Dominican Republic.</p>
</sec>
<ack>
<p>We are thankful to Pedro G. Suarez for his thorough review of the study protocol and manuscripts, to Yaneiris Cuevas from the National Health Service for her input during the design phase of the mobile App, and to Nicole Gal&#x00E1;n from CENISMI for her contributions reviewing the results section.</p>
</ack>
<sec sec-type="COI-statement" id="sec37">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="sec38">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><label>1.</label> <citation citation-type="other"><person-group person-group-type="author"><collab id="coll1">World Health Organization</collab></person-group>. (<year>2015</year>). WHO. Digital health for the end TB strategy - an agenda for action. Available online at: <ext-link xlink:href="http://www.who.int/tb/publications/digitalhealth-TB-agenda/en/" ext-link-type="uri">http://www.who.int/tb/publications/digitalhealth-TB-agenda/en/</ext-link> (Accessed February 20, 2020).</citation></ref>
<ref id="ref2"><label>2.</label> <citation citation-type="other"><person-group person-group-type="author"><name><surname>Moscibrodzki</surname> <given-names>P</given-names></name> <name><surname>Parkinson</surname> <given-names>S</given-names></name> <name><surname>Ferry</surname> <given-names>R</given-names></name> <name><surname>Nwaneri</surname> <given-names>N</given-names></name> <name><surname>Thies</surname> <given-names>W</given-names></name></person-group>. (<year>2021</year>). Mapping the technology landscape of national TB programs: Report [internet]. Geneva, Switzerland; Available online at:<ext-link xlink:href="https://www.theglobalfund.org/en/updates/2021/2021-10-18-mapping-the-technology-landscape-of-national-tb-programs-report/" ext-link-type="uri">https://www.theglobalfund.org/en/updates/2021/2021-10-18-mapping-the-technology-landscape-of-national-tb-programs-report/</ext-link> (Accessed December 20, 2023).</citation></ref>
<ref id="ref3"><label>3.</label> <citation citation-type="other"><person-group person-group-type="author"><collab id="coll2">The Stop TB Partnership</collab></person-group>. (<year>2023</year>). Digital health technology hub [internet]. Available online at: <ext-link xlink:href="https://www.stoptb.org/accelerate-tb-innovations/digital-health-technology-hub" ext-link-type="uri">https://www.stoptb.org/accelerate-tb-innovations/digital-health-technology-hub</ext-link> (Accessed December 20, 2023).</citation></ref>
<ref id="ref4"><label>4.</label> <citation citation-type="other"><person-group person-group-type="author"><collab id="coll3">World Health Organization</collab></person-group>. (<year>2023</year>). Report of the WHO consultation on digital technologies for tuberculosis [internet]. Available online at:<ext-link xlink:href="https://www.who.int/publications-detail-redirect/9789240068254" ext-link-type="uri">https://www.who.int/publications-detail-redirect/9789240068254</ext-link> (Accessed December 20, 2023).</citation></ref>
<ref id="ref5"><label>5.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname> <given-names>LW</given-names></name> <name><surname>Njie-Carr</surname> <given-names>V</given-names></name> <name><surname>Kalenge</surname> <given-names>S</given-names></name> <name><surname>Kelly</surname> <given-names>JF</given-names></name> <name><surname>Bollinger</surname> <given-names>RC</given-names></name> <name><surname>Alamo-Talisuna</surname> <given-names>S</given-names></name></person-group>. <article-title>Perceptions and acceptability of mHealth interventions for improving patient care at a community-based HIV/AIDS clinic in Uganda: a mixed methods study</article-title>. <source>AIDS Care</source>. (<year>2013</year>) <volume>25</volume>:<fpage>874</fpage>&#x2013;<lpage>80</lpage>. doi: <pub-id pub-id-type="doi">10.1080/09540121.2013.774315</pub-id>, PMID: <pub-id pub-id-type="pmid">23452084</pub-id></citation></ref>
<ref id="ref6"><label>6.</label> <citation citation-type="other"><person-group person-group-type="author"><collab id="coll4">World Health Organization</collab></person-group>. (<year>2021</year>). Global Tuberculosis report 2021 [internet]. Available online at: <ext-link xlink:href="https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2021" ext-link-type="uri">https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2021</ext-link> (Accessed October 23, 2021).</citation></ref>
<ref id="ref7"><label>7.</label> <citation citation-type="other"><person-group person-group-type="author"><collab id="coll5">Divisi&#x00F3;n de Tuberculosis, Ministerio de Salud P&#x00FA;blica</collab></person-group>. (<year>2017</year>). Situaci&#x00F3;n del Programa Nacional de Control de la Tuberculosis en la Republica Dominicana-2017&#x2033;. Santo Domingo, Rep&#x00FA;blica Dominicana.</citation></ref>
<ref id="ref8"><label>8.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ruru</surname> <given-names>Y</given-names></name> <name><surname>Matasik</surname> <given-names>M</given-names></name> <name><surname>Oktavian</surname> <given-names>A</given-names></name> <name><surname>Senyorita</surname> <given-names>R</given-names></name> <name><surname>Mirino</surname> <given-names>Y</given-names></name> <name><surname>Tarigan</surname> <given-names>LH</given-names></name> <etal/></person-group>. <article-title>Factors associated with non-adherence during tuberculosis treatment among patients treated with DOTS strategy in Jayapura, Papua Province, Indonesia</article-title>. <source>Glob Health Action</source>. (<year>2018</year>) <volume>11</volume>:<fpage>1510592</fpage>. doi: <pub-id pub-id-type="doi">10.1080/16549716.2018.1510592</pub-id>, PMID: <pub-id pub-id-type="pmid">30394200</pub-id></citation></ref>
<ref id="ref9"><label>9.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>J</given-names></name> <name><surname>Yang</surname> <given-names>Y</given-names></name> <name><surname>Qiao</surname> <given-names>X</given-names></name> <name><surname>Wang</surname> <given-names>L</given-names></name> <name><surname>Bai</surname> <given-names>J</given-names></name> <name><surname>Yangchen</surname> <given-names>T</given-names></name> <etal/></person-group>. <article-title>Factors influencing medication nonadherence to pulmonary Tuberculosis treatment in Tibet, China: a qualitative study from the patient perspective</article-title>. <source>Patient Prefer Adher</source>. (<year>2020</year>) <volume>14</volume>:<fpage>1149</fpage>&#x2013;<lpage>58</lpage>. doi: <pub-id pub-id-type="doi">10.2147/PPA.S252448</pub-id>, PMID: <pub-id pub-id-type="pmid">32764888</pub-id></citation></ref>
<ref id="ref10"><label>10.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sousa</surname> <given-names>GJB</given-names></name> <name><surname>Maranh&#x00E3;o</surname> <given-names>TA</given-names></name> <name><surname>MJS</surname> <given-names>DLT</given-names></name> <name><surname>De Souza</surname> <given-names>JT</given-names></name> <name><surname>TMM</surname> <given-names>M</given-names></name> <name><surname>MLD</surname> <given-names>P</given-names></name></person-group>. <article-title>Prevalence and associated factors of tuberculosis treatment abandonment</article-title>. <source>Rev Esc Enferm USP</source>. (<year>2021</year>) <volume>55</volume>:<fpage>e03767</fpage>. doi: <pub-id pub-id-type="doi">10.1590/S1980-220X2020039203767</pub-id>, PMID: <pub-id pub-id-type="pmid">34320115</pub-id></citation></ref>
<ref id="ref11"><label>11.</label> <citation citation-type="other"><person-group person-group-type="author"><collab id="coll6">World Health Organization</collab></person-group>. (<year>2023</year>). Indicator metadata registry details [internet]. Available online at: <ext-link xlink:href="https://www.who.int/data/gho/indicator-metadata-registry/imr-details/332" ext-link-type="uri">https://www.who.int/data/gho/indicator-metadata-registry/imr-details/332</ext-link> (Accessed December 22, 2023).</citation></ref>
<ref id="ref12"><label>12.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname> <given-names>V</given-names></name></person-group>. <article-title>Tuberculosis treatment-shortening</article-title>. <source>Drug Discov Today</source>. (<year>2024</year>) <volume>29</volume>:<fpage>103955</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.drudis.2024.103955</pub-id>, PMID: <pub-id pub-id-type="pmid">38548262</pub-id></citation></ref>
<ref id="ref13"><label>13.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sazali</surname> <given-names>MF</given-names></name> <name><surname>Rahim</surname> <given-names>SSSA</given-names></name> <name><surname>Mohammad</surname> <given-names>AH</given-names></name> <name><surname>Kadir</surname> <given-names>F</given-names></name> <name><surname>Payus</surname> <given-names>AO</given-names></name> <name><surname>Avoi</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Improving Tuberculosis medication adherence: the potential of integrating digital technology and health belief model</article-title>. <source>Tuberc Respir Dis</source>. (<year>2023</year>) <volume>86</volume>:<fpage>82</fpage>&#x2013;<lpage>93</lpage>. doi: <pub-id pub-id-type="doi">10.4046/trd.2022.0148</pub-id>, PMID: <pub-id pub-id-type="pmid">36597583</pub-id></citation></ref>
<ref id="ref14"><label>14.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alipanah</surname> <given-names>N</given-names></name> <name><surname>Jarlsberg</surname> <given-names>L</given-names></name> <name><surname>Miller</surname> <given-names>C</given-names></name> <name><surname>Linh</surname> <given-names>NN</given-names></name> <name><surname>Falzon</surname> <given-names>D</given-names></name> <name><surname>Jaramillo</surname> <given-names>E</given-names></name> <etal/></person-group>. <article-title>Adherence interventions and outcomes of tuberculosis treatment: a systematic review and meta-analysis of trials and observational studies</article-title>. <source>PLoS Med</source>. (<year>2018</year>) <volume>15</volume>:<fpage>e1002595</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pmed.1002595</pub-id>, PMID: <pub-id pub-id-type="pmid">29969463</pub-id></citation></ref>
<ref id="ref15"><label>15.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hafez</surname> <given-names>G</given-names></name> <name><surname>Van</surname> <given-names>BJFM</given-names></name></person-group>. <article-title>Digital adherence technologies in tuberculosis</article-title>. <source>Lancet Glob Health</source>. (<year>2023</year>) <volume>11</volume>:<fpage>e1341</fpage>&#x2013;<lpage>2</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S2214-109X(23)00308-X</pub-id>, PMID: <pub-id pub-id-type="pmid">37591581</pub-id></citation></ref>
<ref id="ref16"><label>16.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chuck</surname> <given-names>C</given-names></name> <name><surname>Robinson</surname> <given-names>E</given-names></name> <name><surname>Macaraig</surname> <given-names>M</given-names></name> <name><surname>Alexander</surname> <given-names>M</given-names></name> <name><surname>Burzynski</surname> <given-names>J</given-names></name></person-group>. <article-title>Enhancing management of tuberculosis treatment with video directly observed therapy in new York City</article-title>. <source>Int J Tuberc Lung Dis</source>. (<year>2016</year>) <volume>20</volume>:<fpage>588</fpage>&#x2013;<lpage>93</lpage>. doi: <pub-id pub-id-type="doi">10.5588/ijtld.15.0738</pub-id>, PMID: <pub-id pub-id-type="pmid">27084810</pub-id></citation></ref>
<ref id="ref17"><label>17.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holzschuh</surname> <given-names>EL</given-names></name> <name><surname>Province</surname> <given-names>S</given-names></name> <name><surname>Johnson</surname> <given-names>K</given-names></name> <name><surname>Walls</surname> <given-names>C</given-names></name> <name><surname>Shemwell</surname> <given-names>C</given-names></name> <name><surname>Martin</surname> <given-names>G</given-names></name> <etal/></person-group>. <article-title>Use of video directly observed therapy for treatment of latent Tuberculosis infection - Johnson County, Kansas, 2015</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>. (<year>2017</year>) <volume>66</volume>:<fpage>387</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.15585/mmwr.mm6614a3</pub-id>, PMID: <pub-id pub-id-type="pmid">28406884</pub-id></citation></ref>
<ref id="ref18"><label>18.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garfein</surname> <given-names>RS</given-names></name> <name><surname>Liu</surname> <given-names>L</given-names></name> <name><surname>Cuevas-Mota</surname> <given-names>J</given-names></name> <name><surname>Collins</surname> <given-names>K</given-names></name> <name><surname>Mu&#x00F1;oz</surname> <given-names>F</given-names></name> <name><surname>Catanzaro</surname> <given-names>DG</given-names></name> <etal/></person-group>. <article-title>Tuberculosis treatment monitoring by video directly observed therapy in 5 health districts, California, USA</article-title>. <source>Emerg Infect Dis</source>. (<year>2018</year>) <volume>24</volume>:<fpage>1806</fpage>&#x2013;<lpage>15</lpage>. doi: <pub-id pub-id-type="doi">10.3201/eid2410.180459</pub-id>, PMID: <pub-id pub-id-type="pmid">30226154</pub-id></citation></ref>
<ref id="ref19"><label>19.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garfein</surname> <given-names>RS</given-names></name> <name><surname>Doshi</surname> <given-names>RP</given-names></name></person-group>. <article-title>Synchronous and asynchronous video observed therapy (VOT) for tuberculosis treatment adherence monitoring and support</article-title>. <source>J Clin Tuberc Mycobact Dis</source>. (<year>2019</year>) <volume>17</volume>:<fpage>100098</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jctube.2019.100098</pub-id>, PMID: <pub-id pub-id-type="pmid">31867442</pub-id></citation></ref>
<ref id="ref20"><label>20.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mirsaeidi</surname> <given-names>M</given-names></name> <name><surname>Farshidpour</surname> <given-names>M</given-names></name> <name><surname>Banks-Tripp</surname> <given-names>D</given-names></name> <name><surname>Hashmi</surname> <given-names>S</given-names></name> <name><surname>Kujoth</surname> <given-names>C</given-names></name> <name><surname>Schraufnagel</surname> <given-names>D</given-names></name></person-group>. <article-title>Video directly observed therapy for treatment of tuberculosis is patient-oriented and cost-effective</article-title>. <source>Eur Respir J</source>. (<year>2015</year>) <volume>46</volume>:<fpage>871</fpage>&#x2013;<lpage>4</lpage>. doi: <pub-id pub-id-type="doi">10.1183/09031936.00011015</pub-id>, PMID: <pub-id pub-id-type="pmid">25792632</pub-id></citation></ref>
<ref id="ref21"><label>21.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname> <given-names>TA</given-names></name> <name><surname>Pham</surname> <given-names>MT</given-names></name> <name><surname>Nguyen</surname> <given-names>TL</given-names></name> <name><surname>Nguyen</surname> <given-names>VN</given-names></name> <name><surname>Pham</surname> <given-names>DC</given-names></name> <name><surname>Nguyen</surname> <given-names>BH</given-names></name> <etal/></person-group>. <article-title>Video directly observed therapy to support adherence with treatment for tuberculosis in Vietnam: a prospective cohort study</article-title>. <source>Int J Infect Dis</source>. (<year>2017</year>) <volume>65</volume>:<fpage>85</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ijid.2017.09.029</pub-id>, PMID: <pub-id pub-id-type="pmid">29030137</pub-id></citation></ref>
<ref id="ref22"><label>22.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Truong</surname> <given-names>CB</given-names></name> <name><surname>Tanni</surname> <given-names>KA</given-names></name> <name><surname>Qian</surname> <given-names>J</given-names></name></person-group>. <article-title>Video-observed therapy versus directly observed therapy in patients with Tuberculosis</article-title>. <source>Am J Prev Med</source>. (<year>2022</year>) <volume>62</volume>:<fpage>450</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.amepre.2021.10.013</pub-id>, PMID: <pub-id pub-id-type="pmid">34916094</pub-id></citation></ref>
<ref id="ref23"><label>23.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sheet</surname> <given-names>D</given-names></name></person-group>. <article-title>Toward a comprehensive cure: digital information and communication technology is helping to meet health care challenges in India</article-title>. <source>IEEE Pulse</source>. (<year>2016</year>) <volume>7</volume>:<fpage>34</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1109/MPUL.2016.2607140</pub-id>, PMID: <pub-id pub-id-type="pmid">27875116</pub-id></citation></ref>
<ref id="ref24"><label>24.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cattamanchi</surname> <given-names>A</given-names></name> <name><surname>Crowder</surname> <given-names>R</given-names></name> <name><surname>Kityamuwesi</surname> <given-names>A</given-names></name> <name><surname>Kiwanuka</surname> <given-names>N</given-names></name> <name><surname>Lamunu</surname> <given-names>M</given-names></name> <name><surname>Namale</surname> <given-names>C</given-names></name> <etal/></person-group>. <article-title>Digital adherence technology for tuberculosis treatment supervision: a stepped-wedge cluster-randomized trial in Uganda</article-title>. <source>PLoS Med</source>. (<year>2021</year>) <volume>18</volume>:<fpage>e1003628</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pmed.1003628</pub-id>, PMID: <pub-id pub-id-type="pmid">33956802</pub-id></citation></ref>
<ref id="ref25"><label>25.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>X</given-names></name> <name><surname>Thompson</surname> <given-names>J</given-names></name> <name><surname>Dong</surname> <given-names>H</given-names></name> <name><surname>Sweeney</surname> <given-names>S</given-names></name> <name><surname>Li</surname> <given-names>X</given-names></name> <name><surname>Yuan</surname> <given-names>Y</given-names></name> <etal/></person-group>. <article-title>Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomised superiority trial</article-title>. <source>Lancet Glob Health</source>. (<year>2023</year>) <volume>11</volume>:<fpage>e693</fpage>&#x2013;<lpage>703</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S2214-109X(23)00068-2</pub-id>, PMID: <pub-id pub-id-type="pmid">37061308</pub-id></citation></ref>
<ref id="ref26"><label>26.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>Y</given-names></name> <name><surname>Raviglione</surname> <given-names>MC</given-names></name> <name><surname>Flahault</surname> <given-names>A</given-names></name></person-group>. <article-title>Use of digital technology to enhance tuberculosis control: scoping review</article-title>. <source>J Med Internet Res</source>. (<year>2020</year>) <volume>22</volume>:<fpage>e15727</fpage>. doi: <pub-id pub-id-type="doi">10.2196/15727</pub-id>, PMID: <pub-id pub-id-type="pmid">32053111</pub-id></citation></ref>
<ref id="ref27"><label>27.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ngwatu</surname> <given-names>BK</given-names></name> <name><surname>Nsengiyumva</surname> <given-names>NP</given-names></name> <name><surname>Oxlade</surname> <given-names>O</given-names></name> <name><surname>Mappin-Kasirer</surname> <given-names>B</given-names></name> <name><surname>Nguyen</surname> <given-names>NL</given-names></name> <name><surname>Jaramillo</surname> <given-names>E</given-names></name> <etal/></person-group>. <article-title>The impact of digital health technologies on tuberculosis treatment: a systematic review</article-title>. <source>Eur Respir J</source>. (<year>2018</year>) <volume>51</volume>:<fpage>1701596</fpage>. doi: <pub-id pub-id-type="doi">10.1183/13993003.01596-2017</pub-id>, PMID: <pub-id pub-id-type="pmid">29326332</pub-id></citation></ref>
<ref id="ref28"><label>28.</label> <citation citation-type="book"><person-group person-group-type="author"><name><surname>Ewart</surname> <given-names>CK</given-names></name></person-group>. <article-title>How integrative behavioral theory can improve health promotion and disease prevention</article-title> In: <source>Handbook of clinical health psychology: Volume 3 models and perspectives in health psychology</source>. ed. Schneiderman N. <publisher-loc>Washington, DC, US</publisher-loc>: <publisher-name>American Psychological Association</publisher-name> (<year>2004</year>). <fpage>249</fpage>&#x2013;<lpage>89</lpage>.</citation></ref>
<ref id="ref29"><label>29.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hale</surname> <given-names>JL</given-names></name> <name><surname>Householder</surname> <given-names>BJ</given-names></name> <name><surname>Greene</surname> <given-names>KL</given-names></name></person-group>. <article-title>The theory of reasoned action</article-title>. <source>Persuas Handb Dev Theory Pract</source>. (<year>2002</year>) <volume>2002</volume>:<fpage>259</fpage>&#x2013;<lpage>86</lpage>. doi: <pub-id pub-id-type="doi">10.4135/9781412976046.n14</pub-id>, PMID: <pub-id pub-id-type="pmid">34907622</pub-id></citation></ref>
<ref id="ref30"><label>30.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bosnjak</surname> <given-names>M</given-names></name> <name><surname>Ajzen</surname> <given-names>I</given-names></name> <name><surname>Schmidt</surname> <given-names>P</given-names></name></person-group>. <article-title>The theory of planned behavior: selected recent advances and applications</article-title>. <source>Eur J Psychol</source>. (<year>2020</year>) <volume>16</volume>:<fpage>352</fpage>&#x2013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.5964/ejop.v16i3.3107</pub-id>, PMID: <pub-id pub-id-type="pmid">33680187</pub-id></citation></ref>
<ref id="ref31"><label>31.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saunders</surname> <given-names>CH</given-names></name> <name><surname>Sierpe</surname> <given-names>A</given-names></name> <name><surname>Von</surname> <given-names>PC</given-names></name> <name><surname>Kennedy</surname> <given-names>AM</given-names></name> <name><surname>Leviton</surname> <given-names>LC</given-names></name> <name><surname>Bernstein</surname> <given-names>SL</given-names></name> <etal/></person-group>. <article-title>Practical thematic analysis: a guide for multidisciplinary health services research teams engaging in qualitative analysis</article-title>. <source>BMJ</source>. (<year>2023</year>) <volume>381</volume>:<fpage>e074256</fpage>. doi: <pub-id pub-id-type="doi">10.1136/bmj-2022-074256</pub-id>, PMID: <pub-id pub-id-type="pmid">37290778</pub-id></citation></ref>
<ref id="ref32"><label>32.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zurashvili</surname> <given-names>T</given-names></name> <name><surname>Chakhaia</surname> <given-names>T</given-names></name> <name><surname>Kochlamazashvili</surname> <given-names>M</given-names></name> <name><surname>Kamkamidze</surname> <given-names>G</given-names></name> <name><surname>Butsashvili</surname> <given-names>M</given-names></name></person-group>. <article-title>A qualitative study of knowledge, attitude and practice towards TB in Georgia</article-title>. <source>Georgian Med News</source>. (<year>2022</year>) <volume>322</volume>:<fpage>43</fpage>&#x2013;<lpage>7</lpage>. Available at: <ext-link xlink:href="https://www.who.int/publications/i/item/WHO-HTM-TB-2015.21" ext-link-type="uri">https://www.who.int/publications/i/item/WHO-HTM-TB-2015.21</ext-link></citation></ref>
<ref id="ref33"><label>33.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yousif</surname> <given-names>K</given-names></name> <name><surname>Ei Maki</surname> <given-names>M</given-names></name> <name><surname>Babikir</surname> <given-names>RK</given-names></name> <name><surname>Abuaisha</surname> <given-names>H</given-names></name></person-group>. <article-title>The effect of an educational intervention on awareness of various aspects of pulmonary tuberculosis in patients with the disease</article-title>. <source>East Mediterr Health J Rev Sante Mediterr Orient Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit</source>. (<year>2021</year>) <volume>27</volume>:<fpage>287</fpage>&#x2013;<lpage>92</lpage>. doi: <pub-id pub-id-type="doi">10.26719/emhj.20.102</pub-id>, PMID: <pub-id pub-id-type="pmid">33788218</pub-id></citation></ref>
<ref id="ref34"><label>34.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bediang</surname> <given-names>G</given-names></name> <name><surname>Stoll</surname> <given-names>B</given-names></name> <name><surname>Elia</surname> <given-names>N</given-names></name> <name><surname>Abena</surname> <given-names>JL</given-names></name> <name><surname>Geissbuhler</surname> <given-names>A</given-names></name></person-group>. <article-title>SMS reminders to improve adherence and cure of tuberculosis patients in Cameroon (TB-SMS Cameroon): a randomised controlled trial</article-title>. <source>BMC Public Health</source>. (<year>2018</year>) <volume>18</volume>:<fpage>583</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12889-018-5502-x</pub-id>, PMID: <pub-id pub-id-type="pmid">29720146</pub-id></citation></ref>
<ref id="ref35"><label>35.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abdulrahman</surname> <given-names>SA</given-names></name> <name><surname>Rampal</surname> <given-names>L</given-names></name> <name><surname>Ibrahim</surname> <given-names>F</given-names></name> <name><surname>Radhakrishnan</surname> <given-names>AP</given-names></name> <name><surname>Kadir Shahar</surname> <given-names>H</given-names></name> <name><surname>Othman</surname> <given-names>N</given-names></name></person-group>. <article-title>Mobile phone reminders and peer counseling improve adherence and treatment outcomes of patients on ART in Malaysia: a randomized clinical trial</article-title>. <source>PLoS One</source>. (<year>2017</year>) <volume>12</volume>:<fpage>e0177698</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0177698</pub-id>, PMID: <pub-id pub-id-type="pmid">28520768</pub-id></citation></ref>
<ref id="ref36"><label>36.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Badawy</surname> <given-names>SM</given-names></name> <name><surname>Kuhns</surname> <given-names>LM</given-names></name></person-group>. <article-title>Texting and mobile phone app interventions for improving adherence to preventive behavior in adolescents: a systematic review</article-title>. <source>JMIR Mhealth Uhealth</source>. (<year>2017</year>) <volume>5</volume>:<fpage>e50</fpage>. doi: <pub-id pub-id-type="doi">10.2196/mhealth.6837</pub-id>, PMID: <pub-id pub-id-type="pmid">28428157</pub-id></citation></ref>
<ref id="ref37"><label>37.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Iribarren</surname> <given-names>SJ</given-names></name> <name><surname>Beck</surname> <given-names>SL</given-names></name> <name><surname>Pearce</surname> <given-names>PF</given-names></name> <name><surname>Chirico</surname> <given-names>C</given-names></name> <name><surname>Etchevarria</surname> <given-names>M</given-names></name> <name><surname>Rubinstein</surname> <given-names>F</given-names></name></person-group>. <article-title>MHealth intervention development to support patients with active Tuberculosis</article-title>. <source>J Mob Technol Med</source>. (<year>2014</year>) <volume>3</volume>:<fpage>16</fpage>&#x2013;<lpage>27</lpage>. doi: <pub-id pub-id-type="doi">10.7309/jmtm.3.2.4</pub-id>, PMID: <pub-id pub-id-type="pmid">26246859</pub-id></citation></ref>
<ref id="ref38"><label>38.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yzer</surname> <given-names>M</given-names></name></person-group>. <article-title>The integrative model of behavioral prediction as a tool for designing health messages</article-title>. <source>Health Commun Message Des Theory Pract</source>. (<year>2012</year>) <volume>2012</volume>:<fpage>21</fpage>&#x2013;<lpage>40</lpage>.</citation></ref>
<ref id="ref39"><label>39.</label> <citation citation-type="other"><person-group person-group-type="author"><name><surname>Vallejo</surname> <given-names>JS</given-names></name></person-group>. (<year>2023</year>). Peri&#x00F3;dico elDinero. Salario promedio general del sector formal fue de RD$18,711 en primer trimestre 2023. Available online at: <ext-link xlink:href="https://eldinero.com.do/233821/salario-promedio-general-del-sector-formal-fue-de-rd18711-en-primer-trimestre-2023/" ext-link-type="uri">https://eldinero.com.do/233821/salario-promedio-general-del-sector-formal-fue-de-rd18711-en-primer-trimestre-2023/</ext-link> (Accessed December 26, 2023).</citation></ref>
<ref id="ref40"><label>40.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haleem</surname> <given-names>A</given-names></name> <name><surname>Javaid</surname> <given-names>M</given-names></name> <name><surname>Singh</surname> <given-names>RP</given-names></name> <name><surname>Suman</surname> <given-names>R</given-names></name></person-group>. <article-title>Telemedicine for healthcare: capabilities, features, barriers, and applications</article-title>. <source>Sens Int</source>. (<year>2021</year>) <volume>2</volume>:<fpage>100117</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.sintl.2021.100117</pub-id>, PMID: <pub-id pub-id-type="pmid">34806053</pub-id></citation></ref>
<ref id="ref41"><label>41.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Munro</surname> <given-names>SA</given-names></name> <name><surname>Lewin</surname> <given-names>SA</given-names></name> <name><surname>Smith</surname> <given-names>HJ</given-names></name> <name><surname>Engel</surname> <given-names>ME</given-names></name> <name><surname>Fretheim</surname> <given-names>A</given-names></name> <name><surname>Volmink</surname> <given-names>J</given-names></name></person-group>. <article-title>Patient adherence to Tuberculosis treatment: a systematic review of qualitative research</article-title>. <source>PLoS Med</source>. (<year>2007</year>) <volume>4</volume>:<fpage>e238</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pmed.0040238</pub-id>, PMID: <pub-id pub-id-type="pmid">17676945</pub-id></citation></ref>
<ref id="ref42"><label>42.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gebremariam</surname> <given-names>RB</given-names></name> <name><surname>Wolde</surname> <given-names>M</given-names></name> <name><surname>Beyene</surname> <given-names>A</given-names></name></person-group>. <article-title>Determinants of adherence to anti-TB treatment and associated factors among adult TB patients in Gondar city administration, northwest, Ethiopia: based on health belief model perspective</article-title>. <source>J Health Popul Nutr</source>. (<year>2021</year>) <volume>40</volume>:<fpage>49</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s41043-021-00275-6</pub-id>, PMID: <pub-id pub-id-type="pmid">34838120</pub-id></citation></ref>
<ref id="ref43"><label>43.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nezenega</surname> <given-names>ZS</given-names></name> <name><surname>Perimal-Lewis</surname> <given-names>L</given-names></name> <name><surname>Maeder</surname> <given-names>AJ</given-names></name></person-group>. <article-title>Factors influencing patient adherence to Tuberculosis treatment in Ethiopia: a literature review</article-title>. <source>Int J Environ Res Public Health</source>. (<year>2020</year>) <volume>17</volume>:<fpage>5626</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijerph17155626</pub-id>, PMID: <pub-id pub-id-type="pmid">32759876</pub-id></citation></ref>
</ref-list>
</back>
</article>